EC
ARQT icon

EcoR1 Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

EcoR1 Capital’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-500,000
Closed -$4.96M – 57
2024
Q1 		$4.96M Buy
+500,000
New +$3.73M 0.13% 51
2023
Q2 		– Sell
-415,322
Closed -$4.57M – 55
2023
Q1 		$4.57M Hold
415,322
– – 0.15% 39
2022
Q4 		$6.15M Hold
415,322
– – 0.19% 46
2022
Q3 		$7.94M Sell
415,322
-480,181
-54% -$10.9M 0.23% 39
2022
Q2 		$19.1M Hold
895,503
– – 0.66% 28
2022
Q1 		$17.2M Buy
+895,503
New +$15.1M 0.54% 37

Other funds holding ARQT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return